Abstract
Blockade of the renin-angiotensin-aldosterone system (RAAS) offers superior renoprotection in the treatment of patients with hypertension, but the efficacy of RAAS inhibition strongly depends on sodium status, presumably in relation to extracellular volume status. Because assessing volume status by physical examination is challenging, 24-hour urine collection and NT-proBNP levels are useful tools for guiding volume management and achieving sodium status targets.
Original language | English |
---|---|
Pages (from-to) | 397-399 |
Number of pages | 3 |
Journal | Current Hypertension Reports |
Volume | 13 |
Issue number | 6 |
DOIs | |
Publication status | Published - Dec-2011 |
Keywords
- Hypertension
- Chronic kidney disease
- Blood pressure
- Therapy
- Renoprotection
- Sodium
- Renin-angiotensin system
- Renin-angiotensin-aldosterone system
- RAAS blockade
- N-terminal pro-brain natriuretic peptide
- NT-proBNP
- 24-hour urine collection
- Extracellular volume